Vous êtes ici

LeanLife Health Inc.

Liste d'échange: 
CSE
Statut: 
Delisted
Industrie: 
Diversified Industries
Symbole: 
LLP
Indice CSE: 
Devise: 

LeanLife’s products are shelf-stable extractions from flaxseed, a plentiful plant-based source of Omega-3, that give them a significant advantage as a fortified food ingredient.  The products can be used as food additives or as nutraceuticals.  They have been used to make bread, noodles, cheese, yogurt, juice and milk products for the European market.  LeanLife Health’s industry leading and proprietary Omega-3 product formulations are of the highest quality and contain no cholesterol. Products are available in oil, emulsion and powder forms.

Vous êtes ici

LeanLife Health Inc. (LLP)

SEDAR Information

Information d'entreprise

Addresse
380-580 Hornby Street
Vancouver, BC V6C 3B6
Canada
Téléphone
604-764-0518
Fax
604-689-5003
Courriel
SLis@leanlifehealth.com
URL
http://leenlife.com/un/dla-serca
Date d’inscription à la cote
Mercredi, décembre 17, 2014
Agent de transfert
National Securities Administrators Ltd.
Relations avec les investisseurs
Stan Lis
Courriel
investor@leenlifepharma.com
Vérificateur
Charlton & Company

Capitalisation

Capitalisation: 
230884851
Réservé à l'émission: 
29935000

Company Officers

Stan Lis, CEO and Director
Casey Forward, Interim CFO
Carl F. Perez, CTO
Marcin Łukaszewicz, Director
Glen Macdonald, Director
Robert Hall, Director

Bulletins

19/06/2024

2024-0621 - Radiation - LeanLife Health Inc. (LLP)

le 19 juin/June 2024

The common shares of LeanLife Health Inc. will be delisted from the CSE at market close today, June 19, 2024.

LeanLife Health Inc. is currently suspended. See Bulletin 2022-0810.

___________________________